# Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - Inspection Records

Source: https://www.keypedia.com/companies/qilu-pharmaceutical-co-ltd-high-tech-zone-site/94263442-b5c4-4df8-b563-30ae0b9a4206

> Inspection records and compliance data for Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) in Jinan, None. Access full analysis and detailed observations.

---

## Details

- Name: Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site)
- FEI Number: 3003802432
- City: Jinan
- State: None
- Country Name: China
- Address Line 1: 317 Xinluo Road, High Tech Zone
- Zip Code: None
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [483 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - Unknown Date](https://www.keypedia.com/records/483/qilu-pharmaceutical-co-ltd-high-tech-zone-site/57f68425-186a-46f7-be58-9d26c4aa513d) — source: FDA, date: Invalid Date
- [483 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - Unknown Date](https://www.keypedia.com/records/483/qilu-pharmaceutical-co-ltd-high-tech-zone-site/d67404c0-879f-4dd4-8407-58d014e644e8) — source: FDA, date: Invalid Date
- [FDA Inspection 1259422 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2025-01-14](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/f9a6df23-bade-43ab-b78c-7af88b45e77f) — source: FDA, date: January 14, 2025
- [FDA Inspection 1259422 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2025-01-14](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/2861e188-d5bb-4db8-8cb0-dff2030e8ff0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 14, 2025
- [FDA Inspection 1250164 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2024-07-29](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/b8e4e5e9-17da-445f-8952-dedf8a804bf5) — source: FDA, date: July 29, 2024
- [FDA Inspection 1108992 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2019-09-27](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/abe98b75-db71-4a35-8d7b-a04eeb4ba4eb) — classification: No Action Indicated (NAI), source: FDA, date: September 27, 2019
- [FDA Inspection 1052408 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2018-04-17](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/0c4030f5-64da-4dcd-8d4b-cf94c6774baa) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 17, 2018
- [483 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2017-09-20](https://www.keypedia.com/records/483/qilu-pharmaceutical-co-ltd-high-tech-zone-site/3d7aec8f-e0dc-4b88-82af-40bed46c9b2f) — source: FDA, date: September 20, 2017
- [FDA Inspection 1028446 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2017-09-20](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/92c13992-11c8-43d9-a607-1cc46ad0a04e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 20, 2017
- [483 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2015-05-19](https://www.keypedia.com/records/483/qilu-pharmaceutical-co-ltd-high-tech-zone-site/537a5a2e-46c6-42b0-a116-3a7c6a18817d) — source: FDA, date: May 19, 2015
- [FDA Inspection 930087 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2015-05-19](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/ce17088f-a5f7-41e3-bb15-ce170041f50c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 19, 2015
- [483 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2013-07-18](https://www.keypedia.com/records/483/qilu-pharmaceutical-co-ltd-high-tech-zone-site/4de1de8f-387e-477c-9cb4-ff22defa0cba) — source: FDA, date: July 18, 2013
- [FDA Inspection 841923 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2013-07-18](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/aef658fd-646e-49af-b15a-8d466950a781) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 18, 2013

## Related Companies

- [Hospira, Inc., A Pfizer Company](https://www.keypedia.com/companies/hospira-inc-a-pfizer-company/46d63c80-caf7-40db-8325-13fcade5e82c)
- [Sciegen Pharmaceuticals Inc](https://www.keypedia.com/companies/sciegen-pharmaceuticals-inc/814ff2a4-e264-431f-bffa-9932abda619d)
- [Lifecore Biomedical LLC](https://www.keypedia.com/companies/lifecore-biomedical-llc/8ff9e05e-cb2b-42d1-971d-9736e5f0e73c)
- [Osmotica Pharmaceutical US LLC](https://www.keypedia.com/companies/osmotica-pharmaceutical-us-llc/5dae0d09-f070-4928-97f6-cfe7043ff133)
- [Encube Ethicals Pvt. Ltd.](https://www.keypedia.com/companies/encube-ethicals-pvt-ltd/2bba05cc-6e4f-4020-8f97-3e56020b33a2)
- [Innogenix, LLC.](https://www.keypedia.com/companies/innogenix-llc/0b066751-6110-474e-8c0e-cfa7821c4360)
- [Oxalis Labs](https://www.keypedia.com/companies/oxalis-labs/bc19741c-c2c0-43bc-80ad-91eda4acf921)
- [Bora Pharmaceuticals Injectables Inc](https://www.keypedia.com/companies/bora-pharmaceuticals-injectables-inc/d6e15b21-41fb-4f18-9638-893d3f44fcd1)
- [Nephron Sc Inc](https://www.keypedia.com/companies/nephron-sc-inc/2dadfd52-37b7-4da6-9885-864d470c1b18)
- [Glenmark Pharmaceuticals Limited](https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/8a329d32-4a7d-4062-8336-1a4c9455759e)

## Related Officers

- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [Chemist at US Department of Health and Human Services](https://www.keypedia.com/people/felix-maldonado/d7a5c4bd-2aa7-405f-b3c4-17ef35152ab4)
- [Santos E. Camara](https://www.keypedia.com/people/santos-e-camara/18cea942-f6f9-4dec-9ce9-1c01c39009ce)
- [Zachary A. Bogorad](https://www.keypedia.com/people/zachary-a-bogorad/ae582dcd-f893-44a5-98bd-0b55f401577b)